clinical data for axi-cel in lymphoma
Published 6 years ago • 173 plays • Length 6:03Download video MP4
Download video MP3
Similar videos
-
1:17
real-world data for axi-cel in broader dlbcl population
-
3:59
real world data for axi-cel in lymphoma with secondary cns involvement
-
0:57
dr. jacobson on the benefit of axi-cel in relapsed/refractory follicular lymphoma
-
3:05
real-world data on axi-cel for patients with large b-cell lymphoma
-
3:21
radiotherapy bridging for axi-cel in large b-cell lymphoma
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
1:09
dr. neelapu discusses efficacy of axi-cel in large b-cell lymphoma
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
5:14
axi-cel and future of car t-cell therapy in lymphoma
-
9:21
fda approval for axi-cel in nhl
-
7:15
clinical trial data for respective car t-cell therapies
-
2:59
axi-cel in older patients: data from zuma-1 and clinical use
-
0:43
safety findings for axi-cel in patients with dlbcl
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
4:27
cytopenias after axi-cel in r/r large b-cell lymphoma: clinical implications
-
4:51
zuma-5: axi-cel for r/r non-hodgkin lymphoma
-
1:22
dr. jacobson on the safety profile of axi-cel in relapsed/refractory indolent lymphoma
-
3:10
clinical trials and research for diffuse large b-cell lymphoma
-
12:46
understanding car t-cell therapy in lymphoma